Novartis AG
Utility Patent Applications
Last updated:
List of all Novartis AG patents 676 in total
| Status | Patent |
|---|---|
Application | Utility: STABLE PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY Filling date: 23 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS Filling date: 23 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: CIRCULATION OF COMPONENTS DURING MICROFLUIDIZATION AND/OR HOMOGENIZATION OF EMULSIONS Filling date: 23 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE Filling date: 23 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: PROTEIN KINASE C INHIBITORS FOR TREATMENT OF UVEAL MELANOMA Filling date: 23 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: ANTIBODY-CYTOKINE ENGRAFTED PROTEINS AND METHODS OF USE IN THE TREATMENT OF CANCER Filling date: 23 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: TETRACYCLIC PYRIDONE COMPOUNDS AS ANTIVIRALS Filling date: 23 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile Filling date: 23 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: METHODS FOR TREATING OCULAR SURFACE PAIN Filling date: 23 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE Filling date: 23 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: COMBINATIONS OF FGFR4 INHIBITORS AND BILE ACID SEQUESTRANTS Filling date: 23 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: COMBINATION OF C-MET INHIBITOR WITH ANTIBODY MOLECULE TO PD-1 AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: METHODS FOR MAKING CONJUGATES FROM DISULFIDE-CONTAINING PROTEINS Filling date: 23 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: COMBINATION OF PI3K INHIBITOR AND C-MET INHIBITOR Filling date: 23 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: USES OF MYOSTATIN ANTAGONISTS, COMBINATIONS CONTAINING THEM AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING FARNESOID X RECEPTORS Filling date: 23 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: SUBSTITUTED BISPHENYL BUTANOIC ESTER DERIVATIVES AS NEP INHIBITORS Filling date: 23 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: FLOW-THROUGH PARAMAGNETIC PARTICLE-BASED CELL SEPARATION AND PARAMAGNETIC PARTICLE REMOVAL Filling date: 23 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: Pharmaceutical combinations and their use Filling date: 23 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: PHARMACEUTICAL CARRIER DESIGN Filling date: 23 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: COMBINATION THERAPY Filling date: 23 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: SYSTEM AND METHOD FOR AUTOMATED POSITION MAINTENANCE OF AN OPHTHALMIC SURGERY CONE Filling date: 23 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS Filling date: 23 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: ORGANIC COMPOUNDS Filling date: 23 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: USE OF CANAKINUMAB Filling date: 23 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: CHEMICAL PROCESS FOR MANUFACTURING MONOBACTAM ANTIBIOTIC AND INTERMEDIATES THEREOF Filling date: 23 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: THERAPEUTIC COMBINATION OF A THIRD-GENERATION EGFR TYROSINE KINASE INHIBITOR AND A RAF INHIBITOR Filling date: 23 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: USE OF MAVOGLURANT IN THE REDUCTION OF ALCOHOL USE OR IN PREVENTING RELAPSE INTO ALCOHOL USE Filling date: 23 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: COMBINATION THERAPY FOR THE TREATMENT OF CANCER Filling date: 23 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: Parenteral Formulation Comprising Siponimod Filling date: 23 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: METHODS OF TREATMENT WITH ANTI-FACTOR XI/XIA ANTIBODIES Filling date: 23 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR Filling date: 23 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: COMBINATION Filling date: 23 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: METHOD FOR PREPARING AT LEAST PARTIALLY DRIED GRANULES Filling date: 23 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: DOSAGE REGIMENS FOR ANTI-TIM-3 ANTIBODIES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: DIVERGING LIGHT FROM FIBER OPTICS ILLUMINATION DELIVERY SYSTEM Filling date: 23 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: SYRINGE Filling date: 23 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR Filling date: 23 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: ANTI-CCR7 ANTIBODY DRUG CONJUGATES Filling date: 23 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS Filling date: 23 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: USE OF IL-1B BINDING ANTIBODIES FOR THE TREATMENT OF ALCOHOLIC HEPATITIS Filling date: 23 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: TREM2 MUTANTS RESISTANT TO SHEDDASE CLEAVAGE Filling date: 23 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: METHODS OF TREATMENT OF CANCER WITH REDUCED UBB EXPRESSION Filling date: 23 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: Paediatric Compositions For Treating Multiple Sclerosis Filling date: 23 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: IMMUNOSUPPRESSANT FORMULATIONS Filling date: 23 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: ANTIBODIES TO PMEL17 AND CONJUGATES THEREOF Filling date: 23 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: USE OF CANAKINUMAB Filling date: 23 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: AMORPHOUS NANOSTRUCTURED PHARMACEUTICAL MATERIALS Filling date: 23 Sep 2025 Issue date: 25 Jun 2020 |
Showing 400 to 450 of 676 patents.